Genmab AS(GMAB)— 技術面狀態
數據截至2026-11-02 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades +46.3% vs the 50-day and +79.4% vs the 200-day average, 8.4% below the 52-week high and +132.5% off the 52-week low; a golden cross printed 48 sessions ago. Computed from daily closes.
Ranked #20 on today’s Directional Flow — Rising fastest list (scan of 2026-11-02).
移動平均線狀態
- 相對20日均線+29.3%
- 相對50日均線+46.3%
- 相對200日均線+79.4%
- 52週區間低於52週高點8.4% · 高於52週低點132.5%
- 連續走勢連續1個交易日下跌
- 均線交叉黃金交叉(48個交易日前)
- 50日均線交叉股價向上穿越50日均線(87個交易日前)
- 隨機指標%K 78.8 · %D 87.3
FAQ · from the current data · as of 2026-11-02
Quick answers
GMAB目前的Closelook訊號是什麼?
Uptrend stack intact — Trades +46.3% vs the 50-day and +79.4% vs the 200-day average, 8.4% below the 52-week high and +132.5% off the 52-week low; a golden cross printed 48 sessions ago. Computed from daily closes.(截至2026-11-02;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
GMAB目前是否位於50日與200日均線上方?
截至2026-11-02,Genmab AS位於50日均線上方(+46.3%),200日均線上方(+79.4%);距20日均線+29.3%。
GMAB距52週高點有多遠?
截至2026-11-02,低於52週高點8.4%,高於52週低點132.5%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- REGN Regeneron Pharmaceuticals Incindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- EXEL Exelixis Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- VRDN Viridian Therapeutics Incindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- BHVN Biohaven Ltd.industry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- KYMR Kymera Therapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- ADMA ADMA Biologics Incindustry
- IRON Disc Medicine Inc.industry